ARTICLE | Clinical News
BDNF development halted
January 25, 2001 8:00 AM UTC
Regeneron (REGN) and partner Amgen (AMGN) discontinued development of brain-derived neurotrophic factor ( BDNF) to treat amyotrophic lateral sclerosis (ALS) due to a lack of efficacy in clinical trial...